Diagnostic and prognostic value of circulating tumor cells in female breast cancer patientsFootnote

Peer review under responsibility of Alexandria University Faculty of Medicine

Footnote

Available online 12 July 2012

References

• Howlader NNA, Krapcho M, Neyman N, Aminou R, Waldron W, et al. editors. SEER Cancer Statistics Review, 1975–2008. 2010, National Cancer Institute: Bethesda.
   Google Scholar
• Alexandria Cancer Registry, Medical Research Institute, Alexandria University, Egypt. 2007.
   Google Scholar
• H.J.BursteinJ.R.HarrisM.MorrowMalignant tumors of the breastV.T.DeVitaT.S.LawrenceS.A.RosenbergCancer: principles and practice of oncology8th ed.2008Lippincott Williams & WilkinsPhiladelphia16061654
   Google Scholar
• A.JemalR.SiegalE.WardY.HaoJ.XuT.MurrayCancer statisticsCA Cancer J Clin5820087196
   PubMed Web of Science ®Google Scholar
• B.FisherJ.H.JeongS.AndersonJ.BryantE.R.FisherN.WolmarkTwenty-five-year follow-up of a randomized trial comparing radical mastectomy, total mastectomy, and total mastectomy followed by irradiationN Engl J Med3472002567575
   PubMed Web of Science ®Google Scholar
• E.RuoslahtiHow cancer spreadsSci Am27519967277
   Web of Science ®Google Scholar
• A.F.ChambersA.C.GroomI.C.MacDonaldDissemination and growth of cancer cells in metastatic sitesNat Rev Cancer22002563572
   PubMed Web of Science ®Google Scholar
• K.PantelR.H.BrakenhoffDissecting the metastatic cascadeNat Rev Cancer42004448456
   PubMed Web of Science ®Google Scholar
• C.Alix-PanabieresV.MullerK.PantelCurrent status in human breast cancer micrometastasisCurr Opin Oncol192007558563
   Web of Science ®Google Scholar
• S.DawoodM.CristofanilliIntegrating circulating tumor cell assays into the management of breast cancerCurr Treat Options Oncol820078995
   Google Scholar
• R.SainsburyBreastR.M.KirkM.C.WinsletGeneral surgical operations5th ed.2006Churchill Livingstone
   Google Scholar
• C.M.HaskellBreast cancerD.A.CasciatoManual of clinical oncology6th ed.2004Lippincott Williams and WilkinsUSA
   Google Scholar
• B.WeigeltJ.L.PeterseL.J.Van't VeerBreast cancer metastasis: markers and modelsNat Rev Cancer52005591602
   PubMed Web of Science ®Google Scholar
• H.GravesB.J.CzernieckiCirculating tumor cells in breast cancer patients: an evolving role in patient prognosis and disease progressionPathol Res Int20112011621090
   PubMedGoogle Scholar
• M.Alunni-FabbroniM.T.SandriCirculating tumour cells in clinical practice. Methods of detection and possible characterizationMethods502010289297
   PubMed Web of Science ®Google Scholar
• A.SchoenfeldK.H.KrugerJ.GommH.D.SinnettJ.C.GazetN.SacksThe detection of micrometastases in the peripheral blood and bone marrow of patients with breast cancer using immunohistochemistry and reverse transcriptase polymerase chain reaction for keratin 19Eur J Cancer331997854861
   PubMed Web of Science ®Google Scholar
• J.A.López-GuerreroP.B.GilabertE.B.GonzálezM.A.Sanz AlonsoJ.P.PérezA.S.TalensUse of reverse- transcriptase polymerase chain reaction (RT-PCR) for carcinoembryonic antigen, cytokeratin 19, and maspin in the detection of tumor cells in leukapheresis products from patients with breast cancer: comparison with immuno cytochemistryJ Hematother8419995361
   Google Scholar
• J.NiM.Kalff-SuskeR.GentzJ.SchagemanM.BeatoJ.KlugAll human genes of the uteroglobin family are localized on chromosome 11 q 12.2 and form a dense clusterAnn New York Acad Sci92320002542
   Web of Science ®Google Scholar
• P.N.SpanE.WaandersP.MandersJ.J.HeuvelJ.A.FoekensM.A.WatsonMammaglobin is associated with low-grade, steroid receptor-positive breast tumors from postmenopausal patients, and has independent prognostic value for relapse-free survival timeJ Clin Oncol222004691698
   PubMed Web of Science ®Google Scholar
• B.K.ZehentnerD.CarterMammaglobin: a candidate diagnostic marker for breast cancerClin Biochem372004249257
   PubMed Web of Science ®Google Scholar
• M.A.HollingsworthB.J.SwansonMucins in cancer: protection and control of the cell surfaceNat Rev Cancer420044560
   PubMed Web of Science ®Google Scholar
• R.SinghD.BandyopadhyayMUC1: a target molecule for cancer therapyCancer Biol Ther62007481486
   PubMed Web of Science ®Google Scholar
• M.M.ReinholzA.NibbeL.M.JonartK.KitzmannV.J.SumanJ.N.IngleEvaluation of a panel of tumor markers for molecular detection of circulating cancer cells in women with suspected breast cancerClin Cancer Res11200537223732
   PubMed Web of Science ®Google Scholar
• S.RiethdorfV.MüllerL.ZhangT.RauS.LoiblM.KomorDetection and HER2 expression of circulating tumor cells: prospective monitoring in breast cancer patients treated in the neoadjuvant Gepar-Quattro trialClin Cancer Res16201026342645
   PubMed Web of Science ®Google Scholar
• S.ApostolakiM.PerrakiA.PallisV.BozionelouS.AgelakiP.KanellouCirculating HER2 mRNA-positive cells in the peripheral blood of patients with stage I and II breast cancer after the administration of adjuvant chemotherapy: evaluation of their clinical relevanceAnn Oncol182007851858
   PubMed Web of Science ®Google Scholar
• F.C.BidardC.MathiotS.DelalogeE.BrainS.GiachettiP.de CremouxSingle circulating tumor cell detection and overall survival in non metastatic breast cancerAnn Oncol212010729733
   PubMed Web of Science ®Google Scholar
• M.IgnatiadisG.KallergiM.NtouliaM.PerrakiS.ApostolakiM.KafousiPrognostic value of the molecular detection of circulating tumor cells using a multimarker reverse transcription-PCR assay for cytokeratin 19, mammaglobin A, and HER2 in early breast cancerClin Cancer Res14200825932600
   PubMed Web of Science ®Google Scholar
• S.KrishnamurthyM.CristofanilliB.SinghJ.ReubenH.GaoE.N.CohenDetection of minimal residual disease in blood and bone marrow in early stage breast cancerCancer116201033303337
   PubMed Web of Science ®Google Scholar
• B.K.RackC.SchindlbeckU.AndergassenA.SchneeweissT.ZwingersM.LichteneggerUse of circulating tumor cells (CTC) in peripheral blood of breast cancer patients before and after adjuvant chemotherapy to predict risk for relapse: the SUCCESS trialJ Clin Oncol1820101003
   Google Scholar
• T.P.ButlerP.M.GullinoQuantitation of cell shedding into efferent blood of mammary adenocarcinomaCancer Res351975512516
   PubMed Web of Science ®Google Scholar
• Y.S.ChangE.di TomasoD.M.McDonaldR.JonesR.K.JainL.L.MunnMosaic blood vessels in tumors: frequency of cancer cells in contact with flowing bloodProc Natl Acad Sci USA9720001460814613
   PubMed Web of Science ®Google Scholar
• M.G.DenisM.TessierB.DrenoP.LustenbergerCirculating micrometastases following oncological surgeryLancet3471996913
   Web of Science ®Google Scholar
• P.EschwègeF.DumasP.BlanchetV.Le MaireG.BenoitA.JardinHaematogenous dissemination of prostatic epithelial cells during radical prostatectomyLancet346199515281530
   Web of Science ®Google Scholar
• G.MéhesA.WittE.KubistaP.F.AmbrosCirculating breast cancer cells are frequently apoptoticAm J Pathol15920011720
   PubMed Web of Science ®Google Scholar
• S.ApostolakiM.PerrakiG.KallergiM.KafousiS.PapadopoulosA.KotsakisDetection of occult HER2 mRNA-positive tumor cells in the peripheral blood of patients with operable breast cancer: evaluation of their prognostic relevanceBreast Cancer Res Treat1172009525534
   PubMed Web of Science ®Google Scholar
• P.WülfingJ.BorchardH.BuergerS.HeidlK.S.ZänkerL.KieselHER2-positive circulating tumor cells indicate poor clinical outcome in stage I to III breast cancer patientsClin Cancer Res12200617151720
   PubMed Web of Science ®Google Scholar
• N.XenidisM.IgnatiadisS.ApostolakiM.PerrakiK.KalbakisS.AgelakiCytokeratin-19 mRNA-positive circulating tumor cells after adjuvant chemotherapy in patients with early breast cancerJ Clin Oncol27200921772184
   PubMed Web of Science ®Google Scholar
• P.FerroM.C.FranceschiniB.BacigalupoP.DessantiE.FalcoV.FontanaDetection of circulating tumour cells in breast cancer patients using human mammaglobin RT-PCR: association with clinical prognostic factorsAnticancer Res30201023772382
   Web of Science ®Google Scholar
• M.IgnatiadisN.XenidisM.PerrakiS.ApostolakiE.PolitakiM.KafousiDifferent prognostic value of cytokeratin-19 mRNA positive circulating tumor cells according to estrogen receptor and HER2 status in early-stage breast cancerJ Clin Oncol25200751945202
   PubMed Web of Science ®Google Scholar
• J.Y.PiergaF.C.BidardC.MathiotE.BrainS.DelalogeS.GiachettiCirculating tumor cell detection predicts early metastatic relapse after neoadjuvant chemotherapy in large operable and locally advanced breast cancer in a phase II randomized trialClin Cancer Res14200870047010
   PubMed Web of Science ®Google Scholar
• M.J.DuffySerum tumor markers in breast cancer: are they of clinical value?Clin Chem522006345351
   PubMed Web of Science ®Google Scholar
• M.J.DuffyD.EvoyE.W.McDermottCA 15–3: uses and limitation as a biomarker for breast cancerClin Chim Acta411201018691874
   PubMed Web of Science ®Google Scholar
• R.MolinaV.BarakA.van DalenM.J.DuffyR.EinarssonM.GionTumor markers in breast cancer–European Group on Tumor Markers recommendationsTumour Biol262005281293
   PubMed Web of Science ®Google Scholar